• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail

Historical Information on REMS for Extended-Release and Long-Acting Opioid Drugs

This page includes background and historical information on the risk evaluation and mitigation strategy (REMS) for extended-release (ER) and long-acting (LA) opioid drugs. For additional information, please see REMS for Extended-Release and Long-Acting Opioids.